Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database

Journal of Obstetrics and Gynaecology Research

Volumn 39, Issue 1, 2013, Pages 305-310

  Bhat, Rani Akhil ^a   Lim, Yong Kuei ^a   Chia, Yin Nin ^a   Yam, Kwai Lam ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Hormone producing ovarian tumor; Sertoli Leydig cell tumor; Virilizing ovarian tumor

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADJUVANT THERAPY; ADULT; AGED; ANDROBLASTOMA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLITOROMEGALY; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; GENITAL SYSTEM DISEASE; HIRSUTISM; HOARSENESS; HUMAN; HUMAN CELL; LYMPH NODE DISSECTION; MEDICAL RECORD REVIEW; MENSTRUAL IRREGULARITY; OMENTECTOMY; OVARIECTOMY; OVARY CANCER; PERITONEAL BIOPSY; POSTOPERATIVE CARE; RADIOTHERAPY; SALPINGOOOPHORECTOMY; SCHOOL CHILD; SECONDARY AMENORRHEA; TREATMENT DURATION; TUMOR DIFFERENTIATION; VIRILIZATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SERTOLI-LEYDIG CELL TUMOR; TREATMENT OUTCOME;

EID: 84867405422     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.01928.x     Document Type: Article

References (35)

1. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 1985; 9: 543-569.
2. Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF, Woodcock AS. Sertoli-Leydig cell tumors: A clinicopathologic study of 34 cases. Cancer 1981; 48: 187-197.
3. Duncan TJ, Leey S, Achesonz AG, Hammond RH. An ovarian stromal tumor with luteinized cells:An unusual recurrence of an unusual tumor. 2007 IGCS and ESGO, Int J Gynecol Cancer 2008; 18: 168-192.
4. Oliva E, Alvarez T, Young RH. Sertoli cell tumors of the ovary: A clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 2005; 29: 143-156.
5. Scully R, Sobin L. Histologic Typing of Ovarian Tumors, Vol. 9. Berlin, Heidelberg: World Health Organization; Springer-Verlag, 1999.
6. Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer 2003; 97 (10 Suppl): 2631-2642.
7. Outwater EK, Wagner BJ, Mannion C, McLarney JK, Kim B. Sex cord-stromal and steroid cell tumors of the ovary. Radiographics 1998; 18: 1523-1546.
8. Metzinger DS, Webb MJ. Surgical management of Sertoli-Leydig cell tumors of the ovary. CME J Gynecol Oncol 2002; 7: 140-114.
9. Caringella A, Loizzi V, Resta L, Ferreri R, Loverro G. A case of Sertoli-Leydig cell tumor in a postmenopausal woman. Int J Gynecol Cancer 2006; 16: 435-438.
10. Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol 2007; 25: 2944-2951.
11. Zaloudek C, Norris HJ. Sertoli-Leydig tumor of the ovary; a clinicopathological study of 64 intermediate and poorly differentiated neoplasm. Am J Surg Pathol 1984; 8: 405-418.
12. Young RH, Scully RE. Well-differentiated ovarian Sertoli-Leydig cell tumors: A clinicopathological analysis of 23 cases. Int J Gynecol Pathol 1984; 3: 277-290.
13. Sainz de la Cuesta R, Rock JA, Homsi R, Symonds DA, Horowitz IR. Analysis for steroid production of a Sertoli-Leydig cell tumor. Gynaecol Oncol 1994; 52: 276-280.
14. Sternberg WH, Diturandhar HN. Functional ovarian tumors of stromal and sex cord origin. Hum Pathol 1977; 8: 565-582.
15. Wilkinson N, Osborn S, Youngh RH. Sex cord-stromal tumours of the ovary: A review highlighting recent advances. Diagn Histopathol 2008; 14: 388-400.
16. Marcelino M, Nobre E, Conceição J et al. A rare case of hyperandrogenism: Bilateral Leydig cell tumor of the ovary. Acta Med Port 2010; 23: 113-118. Epub 2010 Feb 10.
17. Brown J, Sood AK, Deavers MT, Milojevic L, Gershenson DM. Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted? Gynecol Oncol 2009; 113: 86-90.
18. Young RH, Dudley G, Scully RE. Granulosa cell, Sertoli-Leydig cell, and unclassified sex cord-stromal tumors associated with pregnancy: A clinicopathological analysis of thirty-six cases. Gynecol Oncol 1984; 18: 181-205.
19. Serov SF, Scully RE, Sobin RH. Histological Typing of Ovarian Tumours. International Histologic Classification of Tumours. Geneva: World Health Organization, 1973.
20. Gershenson DM. Management of early ovarian cancer: Germ cell and sex cord-stromal tumors. Gynecol Oncol 1994; 55: S62-S72.
21. Ayhan A, Tuncer ZS, Hakverdi AU, Yuce K, Ayhan A. Sertoli-Leydig cell tumours of the ovary:A clinicopathologic study of 10 cases. Eur J Gynaecol Oncol 1995; 17: 75-78.
22. Hillemanns P, Kimmig R, Arnholdt H. Conservative management of Sertoli-Leydig cell tumor of the ovary. Acta Obstet Gynecol Scand 1997; 76: 604-605.
23. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol 1996; 87: 527-531.
24. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB, Wharton JT. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin and cyclophosphamide. Obstet Gynecol 1987; 70: 765-769.
25. Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A gynecologic oncology group study. Gynecol Oncol 1999; 72: 131-137.
26. Chen FY, Sheu BC, Lin MC, Chow SN, Lin HH. Sertoli-Leydig cell tumor of the ovary. J Formos Med Assoc 2004; 103: 388-391.
27. Sachdeva P, Arora R, Dubey C, Sukhija A, Daga M, Sing DK. Sertoli-Leydig cell tumor: A rare ovarian neoplasm. Case report and review of literature. Gynaecol Endocrinol 2008; 24: 230-234.
28. Reddick RL, Walton LA. Sertoli-Leydig cell tumor of the ovary with teratomatous differentiation. Clinicopathologic considerations. Cancer 1982; 50: 1171-1176.
29. Roth BJ, Greist A, Kubilis PS, Williams SD, Einhorn LH. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: Long-Term follow-up. J Clin Oncol 1988; 6: 1239-1247.
30. Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976; 125: 402-408.
31. Javert CT, Finn WF. Arrhenoblastoma. The incidence of malignancy and the relationship to pregnancy, to sterility and to treatment. Cancer 1951; 4: 60-77.
32. Novak ER, Long JH. Arrhenoblastoma of the ovary. A review of the ovarian tumor registry. Am J Obstet Gynecol 1965; 92: 1082-1093.
33. O'Connor KA, Diddle AW. Arrhenoblastoma. West J Surg Obstet Gynecol 1949; 57: 235-237.
34. Pedowitz P, O'Brien FB. Arrhenoblastoma of the ovary. Review of the literature and report of two cases. Obstet Gynecol 1960; 16: 62-77.
35. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than a-inhibin for ovarian sex cord-stromal neoplasms. An immunohistochemical study of 215 cases. Am J Surg Pathol 2002; 26: 1477-1483.